These medtech companies raised the most VC last year

4 (tied). PulmonX

Redwood City, Calif.
Venture capital raised: $50 million

PulmonX raised $50 million in venture capital during its later stage of development in the second quarter of 2017, according to the MoneyTree Report. This marks the company’s sixth investment sequence. Venture capital investors include De Novo Ventures, HealthCap Venture Capital, Kleiner Perkins Caufield & Byers, Latterell Venture Partners and Montreux Equity Partners.

PulmonX develops an endoscopic lung volume reduction (ELVR) device, known as the Zephyr Endobronchial Valve, for patients with emphysema-induced hyperinflation. The company also developed the Chartis System as an assessment tool for identifying collateral ventilation. Its StratX Lung Analysis Platform is a cloud-based quantitative computed tomography (CT) analysis service.

Next >>

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW